Justices Won't Hear Trade Groups' NY Opioid Tax Challenge

By James Nani (October 4, 2021, 10:44 AM EDT) -- The U.S. Supreme Court on Monday declined to review a challenge by pharmaceutical groups aimed at killing a New York law imposing $600 million in payments on opioid distributors and manufacturers.

Opioid makers and distributors told the Supreme Court the case was a "compelling opportunity" to define the boundaries of the Tax Injunction Act. (AP Photo/J. Scott Applewhite)  The justices declined a petition for a writ of certiorari from trade groups Healthcare Distribution Alliance and Association for Accessible Medicines and opioid maker and distributor SpecGx LLC, which had asked the justices to review the Second Circuit decision that reinstated the New York law last...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!